# A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects

> **NCT01427387** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 44 (actual)

## Conditions studied

- Healthy
- Pharmacokinetics of ASP0456

## Interventions

- **DRUG:** ASP0456
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01427387
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2011-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01427387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01427387, "A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01427387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*